25 XP   0   0   10

Avicanna Inc
Buy, Hold or Sell?

Let's analyse Avicanna together

PenkeI guess you are interested in Avicanna Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avicanna Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Avicanna Inc

I send you an email if I find something interesting about Avicanna Inc.

Quick analysis of Avicanna (30 sec.)










What can you expect buying and holding a share of Avicanna? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.09
Expected worth in 1 year
C$0.14
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
C$0.05
Return On Investment
15.3%

For what price can you sell your share?

Current Price per Share
C$0.32
Expected price per share
C$0.3 - C$0.43
How sure are you?
50%

1. Valuation of Avicanna (5 min.)




Live pricePrice per Share (EOD)

C$0.32

Intrinsic Value Per Share

C$0.79 - C$0.99

Total Value Per Share

C$0.88 - C$1.07

2. Growth of Avicanna (5 min.)




Is Avicanna growing?

Current yearPrevious yearGrowGrow %
How rich?$5.8m$5.7m-$2.1m-62.7%

How much money is Avicanna making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$3.1m$1.5m97.7%
Net Profit Margin-84.4%-415.0%--

How much money comes from the company's main activities?

3. Financial Health of Avicanna (5 min.)




What can you expect buying and holding a share of Avicanna? (5 min.)

Welcome investor! Avicanna's management wants to use your money to grow the business. In return you get a share of Avicanna.

What can you expect buying and holding a share of Avicanna?

First you should know what it really means to hold a share of Avicanna. And how you can make/lose money.

Speculation

The Price per Share of Avicanna is C$0.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avicanna.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avicanna, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.09. Based on the TTM, the Book Value Change Per Share is C$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avicanna.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.02-7.6%-0.02-5.4%-0.03-9.1%-0.04-11.7%-0.03-10.4%
Usd Book Value Change Per Share0.027.5%0.012.8%-0.01-2.1%-0.01-2.3%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.027.5%0.012.8%-0.01-2.1%-0.01-2.3%0.000.8%
Usd Price Per Share0.26-0.28-0.23-0.59-0.49-
Price to Earnings Ratio-2.65--4.51--3.28--4.67--3.89-
Price-to-Total Gains Ratio10.66-10.36--64.91--38.03--38.03-
Price to Book Ratio4.05-10.39-4.88-7.21-6.01-
Price-to-Total Gains Ratio10.66-10.36--64.91--38.03--38.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.234176
Number of shares4270
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.01-0.01
Usd Total Gains Per Share0.01-0.01
Gains per Quarter (4270 shares)38.21-31.16
Gains per Year (4270 shares)152.82-124.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101531430-125-135
203062960-249-260
304584490-374-385
406116020-499-510
507647550-623-635
609179080-748-760
70107010610-873-885
80122312140-997-1010
90137513670-1122-1135
100152815200-1247-1260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.024.00.00.0%0.024.00.00.0%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%7.013.00.035.0%8.013.03.033.3%8.013.03.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%7.013.00.035.0%8.013.03.033.3%8.013.03.033.3%

Fundamentals of Avicanna

About Avicanna Inc

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Fundamental data was last updated by Penke on 2024-04-19 09:09:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Avicanna Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Avicanna earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -50.4% means that $-0.50 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avicanna Inc:

  • The MRQ is -50.4%. The company is making a huge loss. -2
  • The TTM is -84.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-50.4%TTM-84.4%+34.0%
TTM-84.4%YOY-415.0%+330.5%
TTM-84.4%5Y-9,034.6%+8,950.1%
5Y-9,034.6%10Y-8,604.0%-430.5%
1.1.2. Return on Assets

Shows how efficient Avicanna is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • -13.9% Return on Assets means that Avicanna generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avicanna Inc:

  • The MRQ is -13.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.9%TTM-10.4%-3.5%
TTM-10.4%YOY-21.3%+10.9%
TTM-10.4%5Y-19.8%+9.4%
5Y-19.8%10Y-16.9%-2.8%
1.1.3. Return on Equity

Shows how efficient Avicanna is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Avicanna generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avicanna Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-119.7%+119.7%
TTM-119.7%YOY-93.9%-25.9%
TTM-119.7%5Y-124.2%+4.5%
5Y-124.2%10Y-104.3%-20.0%

1.2. Operating Efficiency of Avicanna Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Avicanna is operating .

  • Measures how much profit Avicanna makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avicanna Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-49.6%+49.6%
TTM-49.6%YOY-260.1%+210.5%
TTM-49.6%5Y-8,864.9%+8,815.3%
5Y-8,864.9%10Y-8,462.7%-402.3%
1.2.2. Operating Ratio

Measures how efficient Avicanna is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.18 means that the operating costs are $2.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avicanna Inc:

  • The MRQ is 2.180. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.273. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.180TTM2.273-0.093
TTM2.273YOY3.570-1.297
TTM2.2735Y93.598-91.325
5Y93.59810Y90.571+3.028

1.3. Liquidity of Avicanna Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Avicanna is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.71 means the company has $0.71 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avicanna Inc:

  • The MRQ is 0.707. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.684. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.707TTM0.684+0.023
TTM0.684YOY0.815-0.130
TTM0.6845Y0.918-0.234
5Y0.91810Y0.792+0.125
1.3.2. Quick Ratio

Measures if Avicanna is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avicanna Inc:

  • The MRQ is 0.245. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.240. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.245TTM0.240+0.005
TTM0.240YOY0.320-0.080
TTM0.2405Y0.604-0.363
5Y0.60410Y0.511+0.093

1.4. Solvency of Avicanna Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Avicanna assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avicanna to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.64 means that Avicanna assets are financed with 63.7% credit (debt) and the remaining percentage (100% - 63.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avicanna Inc:

  • The MRQ is 0.637. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.775. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.637TTM0.775-0.138
TTM0.775YOY0.658+0.117
TTM0.7755Y0.547+0.228
5Y0.54710Y0.459+0.089
1.4.2. Debt to Equity Ratio

Measures if Avicanna is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avicanna Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.389-11.389
TTM11.389YOY3.746+7.643
TTM11.3895Y4.553+6.836
5Y4.55310Y3.798+0.755

2. Market Valuation of Avicanna Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avicanna generates.

  • Above 15 is considered overpriced but always compare Avicanna to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -2.65 means the investor is paying $-2.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avicanna Inc:

  • The EOD is -2.420. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.646. Based on the earnings, the company is expensive. -2
  • The TTM is -4.507. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.420MRQ-2.646+0.227
MRQ-2.646TTM-4.507+1.860
TTM-4.507YOY-3.281-1.226
TTM-4.5075Y-4.670+0.163
5Y-4.67010Y-3.892-0.778
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avicanna Inc:

  • The EOD is -8.217. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.987. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.579. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.217MRQ-8.987+0.770
MRQ-8.987TTM-3.579-5.408
TTM-3.579YOY-7.206+3.626
TTM-3.5795Y-6.076+2.497
5Y-6.07610Y-5.063-1.013
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Avicanna is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Avicanna Inc:

  • The EOD is 3.704. Based on the equity, the company is fair priced.
  • The MRQ is 4.052. Based on the equity, the company is fair priced.
  • The TTM is 10.386. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.704MRQ4.052-0.347
MRQ4.052TTM10.386-6.334
TTM10.386YOY4.882+5.504
TTM10.3865Y7.208+3.178
5Y7.20810Y6.006+1.201
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Avicanna Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0330.012+169%-0.009+128%-0.010+130%0.004+812%
Book Value Per Share--0.0860.052+66%0.085+2%0.167-48%0.151-43%
Current Ratio--0.7070.684+3%0.815-13%0.918-23%0.792-11%
Debt To Asset Ratio--0.6370.775-18%0.658-3%0.547+16%0.459+39%
Debt To Equity Ratio---11.389-100%3.746-100%4.553-100%3.798-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.033-0.024-28%-0.040+21%-0.051+54%-0.046+38%
Free Cash Flow Per Share---0.010-0.005-45%-0.020+109%-0.035+258%-0.033+239%
Free Cash Flow To Equity Per Share--0.0000.007-105%0.006-105%0.003-113%0.003-111%
Gross Profit Margin--1.0001.008-1%1.036-3%1.022-2%1.031-3%
Intrinsic Value_10Y_max--0.988--------
Intrinsic Value_10Y_min--0.791--------
Intrinsic Value_1Y_max---0.053--------
Intrinsic Value_1Y_min---0.053--------
Intrinsic Value_3Y_max---0.044--------
Intrinsic Value_3Y_min---0.045--------
Intrinsic Value_5Y_max--0.105--------
Intrinsic Value_5Y_min--0.087--------
Market Cap29532129.280-9%32300766.40035530843.040-9%29301409.520+10%74568626.432-57%62140522.027-48%
Net Profit Margin---0.504-0.844+68%-4.150+723%-90.346+17823%-86.040+16969%
Operating Margin----0.4960%-2.6010%-88.6490%-84.6270%
Operating Ratio--2.1802.273-4%3.570-39%93.598-98%90.571-98%
Pb Ratio3.704-9%4.05210.386-61%4.882-17%7.208-44%6.006-33%
Pe Ratio-2.420+9%-2.646-4.507+70%-3.281+24%-4.670+76%-3.892+47%
Price Per Share0.320-9%0.3500.385-9%0.318+10%0.808-57%0.673-48%
Price To Free Cash Flow Ratio-8.217+9%-8.987-3.579-60%-7.206-20%-6.076-32%-5.063-44%
Price To Total Gains Ratio9.745-9%10.65810.363+3%-64.910+709%-38.033+457%-38.033+457%
Quick Ratio--0.2450.240+2%0.320-23%0.604-59%0.511-52%
Return On Assets---0.139-0.104-25%-0.213+53%-0.198+42%-0.169+22%
Return On Equity----1.1970%-0.9390%-1.2420%-1.0430%
Total Gains Per Share--0.0330.012+169%-0.009+128%-0.010+130%0.004+812%
Usd Book Value--5833990.8303507108.141+66%5707048.228+2%11279641.781-48%10204061.741-43%
Usd Book Value Change Per Share--0.0240.009+169%-0.007+128%-0.007+130%0.003+812%
Usd Book Value Per Share--0.0630.038+66%0.062+2%0.122-48%0.111-43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.024-0.017-28%-0.029+21%-0.037+54%-0.033+38%
Usd Free Cash Flow---657561.085-358907.285-45%-1372517.977+109%-2352081.563+258%-2231723.015+239%
Usd Free Cash Flow Per Share---0.007-0.004-45%-0.015+109%-0.025+258%-0.024+239%
Usd Free Cash Flow To Equity Per Share--0.0000.005-105%0.005-105%0.002-113%0.002-111%
Usd Market Cap21611612.207-9%23637700.85226001470.937-9%21442771.487+10%54569320.823-57%45474434.019-48%
Usd Price Per Share0.234-9%0.2560.282-9%0.232+10%0.591-57%0.493-48%
Usd Profit---2232958.171-1593415.466-29%-3150346.310+41%-4144900.966+86%-3667378.775+64%
Usd Revenue--4429909.5873072001.449+44%740559.829+498%1013503.117+337%848183.063+422%
Usd Total Gains Per Share--0.0240.009+169%-0.007+128%-0.007+130%0.003+812%
 EOD+2 -6MRQTTM+18 -14YOY+25 -75Y+19 -1310Y+19 -13

3.2. Fundamental Score

Let's check the fundamental score of Avicanna Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.420
Price to Book Ratio (EOD)Between0-13.704
Net Profit Margin (MRQ)Greater than0-0.504
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.245
Current Ratio (MRQ)Greater than10.707
Debt to Asset Ratio (MRQ)Less than10.637
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.139
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Avicanna Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.330
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets21,971
Total Liabilities13,999
Total Stockholder Equity-113
 As reported
Total Liabilities 13,999
Total Stockholder Equity+ -113
Total Assets = 21,971

Assets

Total Assets21,971
Total Current Assets8,460
Long-term Assets13,511
Total Current Assets
Cash And Cash Equivalents 477
Net Receivables 2,937
Inventory 4,544
Total Current Assets  (as reported)8,460
Total Current Assets  (calculated)7,958
+/- 502
Long-term Assets
Property Plant Equipment 11,990
Goodwill 334
Intangible Assets 1,186
Long-term Assets  (as reported)13,511
Long-term Assets  (calculated)13,511
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,966
Long-term Liabilities2,033
Total Stockholder Equity-113
Total Current Liabilities
Short Long Term Debt 1,558
Accounts payable 8,870
Other Current Liabilities 1,070
Total Current Liabilities  (as reported)11,966
Total Current Liabilities  (calculated)11,498
+/- 468
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt246
Long-term Liabilities  (as reported)2,033
Long-term Liabilities  (calculated)246
+/- 1,788
Total Stockholder Equity
Total Stockholder Equity (as reported)-113
Total Stockholder Equity (calculated)0
+/- 113
Other
Capital Stock81,025
Common Stock Shares Outstanding 90,677
Net Debt 1,081
Net Invested Capital 1,445
Net Working Capital -3,505
Property Plant and Equipment Gross 14,318



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
28,181
29,661
47,519
43,297
45,164
45,042
42,538
37,863
30,156
30,347
26,951
27,361
22,302
26,295
22,896
21,847
17,619
17,850
22,130
24,707
21,971
21,97124,70722,13017,85017,61921,84722,89626,29522,30227,36126,95130,34730,15637,86342,53845,04245,16443,29747,51929,66128,181000
   > Total Current Assets 
0
0
0
1,192
2,259
17,787
12,287
3,951
5,762
6,399
5,514
6,770
8,837
5,352
6,309
7,354
10,941
9,974
9,344
7,064
6,998
10,353
11,200
8,460
8,46011,20010,3536,9987,0649,3449,97410,9417,3546,3095,3528,8376,7705,5146,3995,7623,95112,28717,7872,2591,192000
       Cash And Cash Equivalents 
0
0
0
69
483
2,055
3,086
442
77
82
101
1,267
3,904
522
523
31
1,576
686
271
1,194
222
111
718
477
4777181112221,1942716861,576315235223,9041,26710182774423,0862,05548369000
       Short-term Investments 
0
0
0
0
0
10,924
3,524
0
0
0
0
1,250
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,25000003,52410,92400000
       Net Receivables 
0
0
0
259
199
397
679
1,203
670
1,428
2,442
1,005
1,607
1,515
422
247
3,024
3,087
2,780
2,149
2,458
3,355
3,807
2,937
2,9373,8073,3552,4582,1492,7803,0873,0242474221,5151,6071,0052,4421,4286701,203679397199259000
       Other Current Assets 
0
0
0
864
1,577
3,277
3,133
705
1,129
931
652
651
168
983
532
901
702
823
658
481
881
0
0
0
0008814816588237029015329831686516529311,1297053,1333,2771,577864000
   > Long-term Assets 
0
0
0
26,989
27,402
29,732
31,010
41,213
39,281
36,139
32,349
23,385
21,510
21,599
21,052
14,948
15,354
12,922
12,503
10,555
10,852
11,777
13,507
13,511
13,51113,50711,77710,85210,55512,50312,92215,35414,94821,05221,59921,51023,38532,34936,13939,28141,21331,01029,73227,40226,989000
       Property Plant Equipment 
0
0
0
16,256
16,676
19,057
20,179
23,162
21,429
21,432
20,344
21,809
19,984
20,128
19,632
14,469
15,091
12,696
12,300
10,387
10,708
11,412
11,868
11,990
11,99011,86811,41210,70810,38712,30012,69615,09114,46919,63220,12819,98421,80920,34421,43221,42923,16220,17919,05716,67616,256000
       Goodwill 
0
0
0
0
0
0
0
3,207
3,207
2,520
0
0
0
0
0
0
0
0
0
0
0
0
0
334
33400000000000002,5203,2073,2070000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
518
518
518
518
180
0
0
0
0
0
0
0
0
0000000018051851851851800000000000
       Intangible Assets 
0
0
0
10,733
10,726
10,675
10,831
11,064
10,864
10,687
10,504
497
447
392
341
299
263
226
203
168
144
365
1,638
1,186
1,1861,63836514416820322626329934139244749710,50410,68710,86411,06410,83110,67510,72610,733000
       Other Assets 
0
0
0
0
0
0
0
3,780
3,780
1,501
1,501
561
561
561
561
0
0
-1
0
0
0
0
0
0
000000-1005615615615611,5011,5013,7803,7800000000
> Total Liabilities 
0
0
0
1,801
4,439
5,327
6,834
15,289
15,428
15,196
16,191
24,139
21,623
13,907
16,529
15,394
15,893
14,170
13,240
14,161
12,958
20,766
19,766
13,999
13,99919,76620,76612,95814,16113,24014,17015,89315,39416,52913,90721,62324,13916,19115,19615,42815,2896,8345,3274,4391,801000
   > Total Current Liabilities 
0
0
0
1,787
3,649
4,127
5,676
8,722
8,925
8,810
9,992
12,825
11,068
10,791
13,646
12,196
12,829
11,099
10,532
11,405
10,379
14,442
17,553
11,966
11,96617,55314,44210,37911,40510,53211,09912,82912,19613,64610,79111,06812,8259,9928,8108,9258,7225,6764,1273,6491,787000
       Short-term Debt 
0
0
0
0
0
225
225
225
225
225
225
0
0
466
1,787
1,246
2,157
2,371
2,487
2,808
1,479
0
0
0
0001,4792,8082,4872,3712,1571,2461,7874660022522522522522522500000
       Short Long Term Debt 
0
0
0
0
0
1,354
2,734
3,319
0
0
0
1,574
425
263
1,578
1,090
2,054
2,323
2,487
2,658
1,329
1,349
1,813
1,558
1,5581,8131,3491,3292,6582,4872,3232,0541,0901,5782634251,5740003,3192,7341,35400000
       Accounts payable 
0
0
0
1,456
2,486
2,548
2,717
5,178
5,271
6,336
4,815
6,562
6,127
6,131
7,470
7,289
6,590
4,898
3,967
4,753
4,689
8,133
9,250
8,870
8,8709,2508,1334,6894,7533,9674,8986,5907,2897,4706,1316,1276,5624,8156,3365,2715,1782,7172,5482,4861,456000
       Other Current Liabilities 
0
0
0
331
1,163
1,354
2,734
3,319
3,428
2,250
4,952
4,485
4,312
4,173
4,177
3,660
4,082
3,831
4,078
3,844
4,210
0
1,165
1,070
1,0701,16504,2103,8444,0783,8314,0823,6604,1774,1734,3124,4854,9522,2503,4283,3192,7341,3541,163331000
   > Long-term Liabilities 
0
0
0
14
790
1,199
1,157
6,567
6,504
6,386
6,199
3,421
3,267
3,115
2,883
3,198
3,064
3,070
2,707
2,755
2,579
2,401
2,213
2,033
2,0332,2132,4012,5792,7552,7073,0703,0643,1982,8833,1153,2673,4216,1996,3866,5046,5671,1571,19979014000
       Long term Debt Total 
0
0
0
0
693
1,108
1,077
1,046
1,014
983
950
161
107
57
0
416
383
306
249
401
329
255
0
0
002553294012493063834160571071619509831,0141,0461,0771,1086930000
       Other Liabilities 
0
0
0
0
97
92
80
5,521
5,489
5,403
5,249
3,260
3,159
3,059
2,883
2,782
2,681
2,764
2,458
0
2,250
0
0
0
0002,25002,4582,7642,6812,7822,8833,0593,1593,2605,2495,4035,4895,5218092970000
> Total Stockholder Equity
0
0
0
18,309
17,327
33,179
27,564
22,387
22,185
18,292
14,130
6,016
8,725
6,121
3,835
1,146
3,900
2,486
2,542
-384
1,173
1,364
1,025
-113
-1131,0251,3641,173-3842,5422,4863,9001,1463,8356,1218,7256,01614,13018,29222,18522,38727,56433,17917,32718,309000
   Common Stock
0
0
0
21,492
23,645
30,698
45,870
46,033
47,582
49,999
52,280
57,469
62,851
62,851
63,088
66,244
68,628
70,502
72,649
74,894
78,320
80,045
0
0
0080,04578,32074,89472,64970,50268,62866,24463,08862,85162,85157,46952,28049,99947,58246,03345,87030,69823,64521,492000
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000-2,344-2,971-2,309-2,215-2,891-4,159-4,037-3,59400-2,901-1,851-1,068-1,125-1,903-894-221-189000
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
6,734
7,341
21,391
7,685
8,279
9,125
10,546
11,838
10,584
10,882
14,593
15,089
16,469
16,935
17,364
18,157
18,522
18,449
-2,183
0
0
00-2,18318,44918,52218,15717,36416,93516,46915,08914,59310,88210,58411,83810,5469,1258,2797,68521,3917,3416,734000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue16,791
Cost of Revenue-10,133
Gross Profit6,6596,659
 
Operating Income (+$)
Gross Profit6,659
Operating Expense-25,171
Operating Income-8,380-18,512
 
Operating Expense (+$)
Research Development331
Selling General Administrative13,501
Selling And Marketing Expenses0
Operating Expense25,17113,831
 
Net Interest Income (+$)
Interest Income0
Interest Expense-610
Other Finance Cost-0
Net Interest Income-610
 
Pretax Income (+$)
Operating Income-8,380
Net Interest Income-610
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,743-8,627
EBIT - interestExpense = -610
-8,743
-8,133
Interest Expense610
Earnings Before Interest and Taxes (EBIT)0-8,133
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-8,743
Tax Provision-0
Net Income From Continuing Ops-8,743-8,743
Net Income-8,743
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net247610
 

Technical Analysis of Avicanna
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Avicanna. The general trend of Avicanna is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Avicanna's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Avicanna Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.32 < 0.33 < 0.43.

The bearish price targets are: 0.3 > 0.3 > 0.3.

Tweet this
Avicanna Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Avicanna Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Avicanna Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Avicanna Inc.

Avicanna Inc Daily Moving Average Convergence/Divergence (MACD) ChartAvicanna Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Avicanna Inc. The current adx is .

Avicanna Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Avicanna Inc.

Avicanna Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Avicanna Inc.

Avicanna Inc Daily Relative Strength Index (RSI) ChartAvicanna Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Avicanna Inc.

Avicanna Inc Daily Stochastic Oscillator ChartAvicanna Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Avicanna Inc.

Avicanna Inc Daily Commodity Channel Index (CCI) ChartAvicanna Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Avicanna Inc.

Avicanna Inc Daily Chande Momentum Oscillator (CMO) ChartAvicanna Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Avicanna Inc.

Avicanna Inc Daily Williams %R ChartAvicanna Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Avicanna Inc.

Avicanna Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Avicanna Inc.

Avicanna Inc Daily Average True Range (ATR) ChartAvicanna Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Avicanna Inc.

Avicanna Inc Daily On-Balance Volume (OBV) ChartAvicanna Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Avicanna Inc.

Avicanna Inc Daily Money Flow Index (MFI) ChartAvicanna Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Avicanna Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Avicanna Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Avicanna Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.330
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Avicanna with someone you think should read this too:
  • Are you bullish or bearish on Avicanna? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Avicanna? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Avicanna Inc

I send you an email if I find something interesting about Avicanna Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Avicanna Inc.

Receive notifications about Avicanna Inc in your mailbox!